L. Tussey

发表

Safety and immunogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adults.

David N. Taylor, L. Stanberry, C. Turley, 2011, Vaccine.

Standardization of cytokine flow cytometry assays

M. Altfeld, R. Koup, V. Maino, 2005, BMC Immunology.

Heparan Sulfate Proteoglycan Isoforms of the CD44 Hyaluronan Receptor Induced in Human Inflammatory Macrophages Can Function as Paracrine Regulators of Fibroblast Growth Factor Action*

D. Jackson, L. Tussey, N. Athanasou, 2000, The Journal of Biological Chemistry.

Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine.

Mary S. Wu, G. Ogg, G. Widera, 2000, Vaccine.

Detergent enhances binding of a secreted HLA-A2 molecule to solid phase peptides.

J. Frelinger, L. Tussey, 1991, Human immunology.

Functionally distinct CD8+ memory T cell subsets in persistent EBV infection are differentiated by migratory receptor expression

L. Tussey, A. Gallimore, R. Vessey, 2000, European journal of immunology.

Mamu-A*01 Allele-Mediated Attenuation of Disease Progression in Simian-Human Immunodeficiency Virus Infection

J. Shiver, W. Schleif, E. Emini, 2002, Journal of Virology.

Development of VAX128, a recombinant hemagglutinin (HA) influenza-flagellin fusion vaccine with improved safety and immune response.

J. Treanor, Langzhou Song, David N. Taylor, 2012, Vaccine.

Genetic evidence for difference between intracellular and extracellular peptides in influenza A matrix peptide-specific CTL recognition.

R. Moots, J. Frelinger, A. McMichael, 1995, Journal of immunology.

Immunogenicity and Efficacy of Flagellin-Fused Vaccine Candidates Targeting 2009 Pandemic H1N1 Influenza in Mice

Langzhou Song, Bruce Weaver, L. Tussey, 2011, PloS one.

Flagellin-HA vaccines protect ferrets and mice against H5N1 highly pathogenic avian influenza virus (HPAIV) infections.

Langzhou Song, Bruce Weaver, D. Noah, 2012, Vaccine.

Recombinant vesicular stomatitis vaccine against Nipah virus has a favorable safety profile: Model for assessment of live vaccines with neurotropic potential

R. J. Hawks, T. Monath, H. Spratt, 2022, PLoS pathogens.

Superior efficacy of a recombinant flagellin:H5N1 HA globular head vaccine is determined by the placement of the globular head within flagellin.

Langzhou Song, Bruce Weaver, L. Tussey, 2009, Vaccine.

Integrase Inhibitors and Cellular Immunity Suppress Retroviral Replication in Rhesus Macaques

D. Hazuda, J. Shiver, W. Schleif, 2004, Science.

Memory T cells and vaccines.

M. Washabaugh, N. Chirmule, L. Tussey, 2003, Vaccine.

Safety and immunogenicity of a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125) in healthy young adults.

J. Treanor, Langzhou Song, David N. Taylor, 2010, Vaccine.

A point mutation in HLA-A*0201 results in failure to bind the TAP complex and to present virus-derived peptides to CTL.

J. Frelinger, L. Tussey, M. Matsui, 1996, Immunity.

Attenuation of Simian Immunodeficiency Virus SIVmac239 Infection by Prophylactic Immunization with DNA and Recombinant Adenoviral Vaccine Vectors Expressing Gag

D. Watkins, D. O’Connor, J. Shiver, 2005, Journal of Virology.

Immunogenic HIV variant peptides that bind to HLA-B8 can fail to stimulate cytotoxic T lymphocyte responses.

P. Klenerman, A. Edwards, P. Giangrande, 1995, Journal of immunology.

Antigen burden is major determinant of human immunodeficiency virus-specific CD8+ T cell maturation state: potential implications for therapeutic immunization.

J. Shiver, R. Steigbigel, P. Goepfert, 2003, The Journal of infectious diseases.

Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin.

R. K. Evans, Y. Huang, Langzhou Song, 2008, Vaccine.

Analysis of mutant HLA-A2 molecules. Differential effects on peptide binding and CTL recognition.

J. Frelinger, A. McMichael, L. Tussey, 1994, Journal of immunology.

HLA-A2 subtypes are functionally distinct in peptide binding and presentation

H. Rammensee, S. Stevanović, S. Rowland-Jones, 1995, The Journal of experimental medicine.

Mapping and binding analysis of peptides derived from the tumor-associated antigen survivin for eight HLA alleles.

L. Tussey, Chaoyuan Chen, Judith Singleton, 2005, Cancer immunity.

Immunopotentiation of Trivalent Influenza Vaccine When Given with VAX102, a Recombinant Influenza M2e Vaccine Fused to the TLR5 Ligand Flagellin

Uma Kavita, M. Rock, David N. Taylor, 2010, PloS one.

Antibody Recognition of the Pandemic H1N1 Influenza Virus Hemagglutinin Receptor Binding Site

James E. Crowe, Andrew B. Ward, Xueyong Zhu, 2013, Journal of Virology.

Engagement of a T cell receptor by major histocompatibility complex irrespective of peptide

J. Bell, A. McMichael, B. Jakobsen, 1997, European journal of immunology.

Different MHC class I alleles compete for presentation of overlapping viral epitopes.

S. Rowland-Jones, P. Cresswell, J. Frelinger, 1995, Immunity.

Induction of a potent immune response in the elderly using the TLR-5 agonist, flagellin, with a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125, STF2.HA1 SI).

J. Treanor, David N. Taylor, T. Fitzgerald, 2011, Vaccine.

A rationally designed form of the TLR5 agonist, flagellin, supports superior immunogenicity of Influenza B globular head vaccines.

Langzhou Song, L. Tussey, Ge Liu, 2014, Vaccine.

Efficacious Recombinant Influenza Vaccines Produced by High Yield Bacterial Expression: A Solution to Global Pandemic and Seasonal Needs

Y. Huang, Langzhou Song, L. Tussey, 2008, PloS one.

Intracellular staining for HIV-specific IFN-gamma production: statistical analyses establish reproducibility and criteria for distinguishing positive responses.

J. Shiver, T. Fu, L. Tussey, 2003, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Phase 1 Safety and Immunogenicity Study of a Quadrivalent Seasonal Flu Vaccine Comprising Recombinant Hemagglutinin-Flagellin Fusion Proteins

Langzhou Song, L. Tussey, Ge Liu, 2016, Open forum infectious diseases.

The effect of early versus delayed challenge after vaccination in controlling SHIV 89.6P infection.

Leslie L. Chavez, A. Perelson, M. Davenport, 2008, Virology.

Immunogenicity and Efficacy of Flagellin-Envelope Fusion Dengue Vaccines in Mice and Monkeys

D. Beasley, Langzhou Song, Wenzhe Liu, 2015, Clinical and Vaccine Immunology.

Efficacy of a vaccine that links viral epitopes to flagellin in protecting aged mice from influenza viral infection.

L. Tussey, U. Kavita, Jie Tang, 2011, Vaccine.

Receptor Binding Site H1N1 Influenza Virus Hemagglutinin Antibody Recognition of the Pandemic

N. S. Laursen, I. Wilson, J. Crowe, 2013 .

Development of Flagellin: Envelope (E) Fusion Dengue Vaccines: Immunogenicity and

Langzhou Song, Wenzhe Liu, L. Tussey, 2015 .

Safety and immunogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adults.

David N. Taylor, L. Stanberry, C. Turley, 2011, Vaccine.